Seas Biotech Profile
Key Indicators
- Authorised Capital ₹ 22.32 Cr
as on 30-10-2024
- Paid Up Capital ₹ 22.32 Cr
as on 30-10-2024
- Company Age 3 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 153.12 Cr
as on 30-10-2024
- Revenue %
(FY 2023)
- Ebitda
- Net Worth 576.64%
(FY 2023)
- Total Assets 765.24%
(FY 2023)
About Seas Biotech
The Company is engaged in the Environment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 22.32 Cr and a paid-up capital of Rs 22.32 Cr.
The company currently has active open charges totaling ₹153.12 Cr.
The Key Managerial Personnel (KMP) at Seas Biotech Private Limited India is Seema Sharma as COMPANY SECRETARY. Mukesh Jalan, Ajay Jagati, Rumi Jalan, and Five other members serve as directors at the Company.
- CIN/LLPIN
U24230AS2021PTC021681
- Company No.
021681
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jul 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Company Details
- Location
Kamrup, Assam, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Seas Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Seema Sharma  | Company Secretary | 02-Jan-2024 | Current |
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nistha Jalan | Director | 28-Jul-2021 | Current |
| Mukesh Jalan | Director | 28-Jul-2021 | Current |
| Ajay Jagati | Director | 10-May-2022 | Current |
| Rumi Jalan | Director | 28-Jul-2021 | Current |
| Samarth Harlalka | Director | 28-Jul-2021 | Current |
| Harsh Jagati | Director | 10-May-2022 | Current |
Financial Performance and Corporate Structure Insights of Seas Biotech.
Seas Biotech Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 576.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Seas Biotech?
In 2023, Seas Biotech had a promoter holding of 97.01% and a public holding of 2.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sadguru Engineers & Allied Services Private LimitedActive 13 years 3 monthsMukesh Jalan and Rumi Jalan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 24 Sep 2024 | ₹0.95 M | Open |
Canara Bank Creation Date: 24 Sep 2024 | ₹1.45 M | Open |
Hdfc Bank Limited Creation Date: 27 Jun 2023 | ₹0.76 M | Open |
How Many Employees Work at Seas Biotech?
Seas Biotech has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Seas Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Seas Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
